Cannabis Law Report

AUGUST 31, 2021

For her part, Marie Millard, executive director of the Luces Panama Foundation, said that the approval of the legislative initiative will give patients quality of life, specifically for people with epilepsy who take two and three medications and do not work for them.

Legalization 100

Legalization Epilepsy Medicine Chronic Pain 100

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

MedicalJane

OCTOBER 3, 2019

The study examines the effect of the cannabinoid Cannabidivarin, more commonly referred to as CBDV , on irritability and repetitive behaviors in children with autism spectrum disorder. The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

Veriheal

JULY 21, 2022

This month, patients will no longer require a medical cannabis card to participate in Virginia’s medical cannabis program. More patients in the program is better for all of the processors, but the real winners in this are the patients in having to not go through so much red tape to get enrolled into the program,” Strand said.

Access 105

Access Dispensary Patients Programs 105

Veriheal

MARCH 1, 2021

However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . That doesn’t mean you can’t access a green state’s medical marijuana programs, though. Let’s take a look at which US states that have a reciprocity program for guests that are cannabis patients.

Patients 119

Patients Marijuana Concentrates Recreational 119

SpeedWeed

APRIL 29, 2021

Texas passed a bill through the House of Representatives today, titled HB 1535, that would expand the state’s medical cannabis program to cover more conditions, and therefore, service more people who rely on the plant. The program has fewer enrolled patients and businesses than most other states because of its extreme restrictions. “To

Programs 52

Programs Chronic Pain Access Patients 52

Cannabis Law Report

JULY 13, 2021

The tools, able to sequence the equivalent of 20,000 cannabis genomes per week, flag attributes such as growth rate, bud size, cannabinoid profile and disease resistance. This helps scientists zero in on strains that would likely be most effective in treating various conditions such as epilepsy, multiple sclerosis and cancer.

Medicine 81

Medicine Research and Development Agriculture Compliance 81

MassRoots

MARCH 7, 2019

House Bill 136 was overwhelmingly approved in a vote of 16 to one after committee members heard from constituents who suffer from health problems such as epilepsy and chronic pain. Program regulation and licensing would be the responsibility of the Kentucky Department of Alcoholic Beverage and Cannabis Control.

Chronic Pain 91

Chronic Pain Epilepsy Legislation Cannabis 91

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. The bill would also only allow patients that are qualified for their program to utilize products such as oral tablets, gels, creams, lozenges, and patches.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system.

CBD 105

CBD DEA Research and Development Hemp 105

The Cannigma

SEPTEMBER 13, 2021

Most notably, scientist Raphael Mechoualm of Hebrew University of Jeruslaem, is credited with isolating tetrahydrocannabinol (THC), as well the cannabinoid 2-AG and anandamide. In the cannabis industry and the scientific community, Israel has a well-earned reputation as a global leader in cannabis research.

Legalization 120

Legalization Decriminalization Patients Cannabis 120

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. We could potentially develop north of 11,000 drugs that are cannabinoid-based. federal law, from which point, informed choices can be made about the use of cannabis and cannabinoids. territories.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Medicine 105

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Veriheal

JULY 7, 2023

Plants hit with HLVd show issues like yellow leaves, abnormal branching, stunted development, and nearly 50% loss in cannabinoid production. Rabon’s bill seeks to give patients with qualifying conditions like cancer, epilepsy, PTSD, and multiple sclerosis access to medical cannabis. Do you think Sen. Let us know in the comments!

Legalization 97

Legalization Clinical Trials Research and Development History 97

The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 145

Law Legalization Clinical Trials CBD 145

Cannabis Law Report

JULY 14, 2021

SB 711 recognizes that “modern medical research has found that cannabis and cannabinoid compounds are effective at alleviating pain, nausea, and other symptoms associated with several debilitating medical conditions.”. SB 711 would make medical marijuana available to “qualified patients” with a physician’s written certification.

Legislation 81

Legislation Seed-To-Sale Marijuana Packaging 81

Veriheal

DECEMBER 28, 2021

Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S. Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

LifeCannMD

APRIL 28, 2025

It is sought after because it contains all the cannabinoids (the highest concentrate of THC), terpenes, and other compounds found in the cannabis plant. And countless patients with conditions ranging from multiple sclerosis to epilepsy, insomnia to chronic pain, report finding relief with RSO. Their stories are powerful and moving.

History 82

History Chronic Pain Research and Development Oil 82

MMJ Recs

NOVEMBER 24, 2023

In this guide, we’ll explore the landscape of Virginia’s MMJ program, the available medical marijuana strains, and the various products designed to improve the well-being of patients. These strains are cultivated to contain specific levels of cannabinoids, including THC and CBD, to address different health needs.

Strains 52

Strains Chronic Pain Indica Patients 52

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

MassRoots

MAY 12, 2020

As a beacon of hope for patients in Georgia, an executive director has finally been appointed by the Access to Medical Cannabis Commission to oversee the next stages of development for the state’s medical marijuana program. In five years of program development, patients still have no way to legally purchase the oil within state lines.

Oil 53

Oil Programs Access Patients 53

Sensi Seeds

DECEMBER 10, 2018

For the time being, and thanks to the onset of a new era of cannabis legalization, thousands of studies on cannabis and cannabinoids are published each year by the scientific community. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.

Medicine 81

Medicine Research and Development Data Policy 81

Canna Care Docs

SEPTEMBER 18, 2020

A medical provider may recommend medical cannabis to treat any condition that they feel may benefit from medical cannabis and cannabinoid-based therapies. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. July 2020 brought substantial changes to the medical cannabis program.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Medicinal Marijuana Association

AUGUST 27, 2019

Based on such revelations, programs such as the one established byIsraeli Ministry of Health are able to provide eligible patients with the necessary permits to legally purchase medical cannabis. The long list of medical conditions which medical cannabis helps to alleviate is all thanks to the revolutionary discoveries made by Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. Prior to this week, the U.S. Epidiolex contains less than 0.1

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Healer

NOVEMBER 24, 2021

CBGA in a mouse model of epilepsy. If you enjoyed this recording and are interested in watching more, enroll in the Healer Certified Training program for access to 35+ recordings with time codes and research abstracts. CBG and brain cancer cells. CBG and breast cancer cells.

Epilepsy 52

Epilepsy Topical Programs Access 52

Healer

NOVEMBER 24, 2021

CBGA in a mouse model of epilepsy. If you enjoyed this recording and are interested in watching more, enroll in the Healer Certified Training program for access to 35+ recordings with time codes and research abstracts. CBG and brain cancer cells. CBG and breast cancer cells.

Epilepsy 52

Epilepsy Topical Programs Access 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Commence clinical program in PTSD.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

MedicalJane

JUNE 29, 2018

There is no universal handbook for a medical cannabis program. The best way to become familiar with your state’s medical marijuana program is to visit its official website. For example, Pennsylvania and New York practitioners need to complete an approved 4-hour course to be able to participate in their State’s program.

Patients 83

Patients Legalization Conditions Treatment 83

The Cannigma

JANUARY 31, 2021

He said the organization also encourages members to take part in charity events (like 10k and 5k runs) that raise money and awareness for diseases that cannabis can potentially help treat, such as multiple sclerosis , cancer , and epilepsy. Is working out high easier? A woman trail running in the woods (thevisualsyouneed/123r).

THC 145

THC Cannabis Environment CBD 145

SpeedWeed

FEBRUARY 27, 2021

The Virginia legislature has passed bills to modify the state’s medical marijuana program to allow for the production and sale of herbal forms of cannabis. The legalization of medical marijuana in Virginia began with a strictly limited 2015 law that allowed for CBD and THC-A oils to be used by patients with severe epilepsy.

Marijuana 52

Marijuana Patients Oil Programs 52

MMJ Recs

JUNE 19, 2024

In Texas, the Compassionate Use Program (CUP) governs the use of medical marijuana for qualifying patients. This program allows for the legal use of low-THC cannabis oil for specific medical conditions. To be eligible for medical marijuana in Texas, patients must meet certain criteria set forth by state regulations.

Conditions 52

Conditions Marijuana Treatment Patients 52

Healer

FEBRUARY 11, 2022

THC then interacts with cannabinoid receptors (CB1 and CB2), widely distributed throughout the body, to produce most of its healing effects. For some conditions, like epilepsy, surprisingly small amounts can make a big difference in some individuals. smoking, vaporizing, high-temperature processing). How much THCA should a person use?

Tincture 52

Tincture THC Epilepsy Cannabinoids 52

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. Eric Hollander, director of the Autism and Spectrum Program and Anxiety and Depression Program at Montefiore Hospital.

Research and Development 40

Research and Development Epilepsy Clinical Trials Treatment 40

Ellementa

NOVEMBER 4, 2019

CBD research shows it can be effective in treating severe forms of epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome (LGS). ” According to cannabinoid researcher, Dr. Ethan Russo, there’s a better term to use when describing CBD. CBD as an anti-seizure medication is affecting the mind. Lights seemed brighter.

CBD 14

CBD Tincture Blood Pressure THC 14